Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 1
2013 2
2014 4
2015 1
2020 3
2021 1
2022 3
2023 3
2024 1
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of automated insulin delivery in pregnant women with type 1 diabetes: a meta-analysis and trial sequential analysis of randomized controlled trials.
Teixeira T, Godoi A, Romeiro P, Novaes JVLC, de Freitas Faria FM, Pereira S, Lamounier RN. Teixeira T, et al. Acta Diabetol. 2024 Jul;61(7):831-840. doi: 10.1007/s00592-024-02284-3. Epub 2024 May 3. Acta Diabetol. 2024. PMID: 38700546 Review.
BACKGROUND: Automated insulin delivery (AID) devices have shown to be a promising treatment to improve glycemic control in patients with type 1 diabetes mellitus (T1DM). ...CONCLUSION: Our findings suggest that AID systems can significantly improve nocturn …
BACKGROUND: Automated insulin delivery (AID) devices have shown to be a promising treatment to improve glycemic control …
The efficacy of automated insulin delivery systems in children and adolescents with type 1 diabetes Mellitus: A systematic review and meta-analysis of randomized controlled trials.
Michou P, Gkiourtzis N, Christoforidis A, Kotanidou EP, Galli-Tsinopoulou A. Michou P, et al. Diabetes Res Clin Pract. 2023 May;199:110678. doi: 10.1016/j.diabres.2023.110678. Epub 2023 Apr 23. Diabetes Res Clin Pract. 2023. PMID: 37094750
Technological advances have led to the development of automated insulin delivery (AID) systems, aiming to optimize the quality of life of patients with T1D. ...Further RCTs examining the effect of AID systems on nocturnal hypoglycemia, under fre …
Technological advances have led to the development of automated insulin delivery (AID) systems, aiming to optimize the …
Efficacy and safety of a tubeless open-source hybrid automated insulin delivery use at home among adults with type 1 diabetes mellitus: Results from a 26-week, free-living, randomized crossover trial.
Lei M, Ling P, Lin B, Lv J, Liu Z, Zhou Y, Deng H, Yang D, Wang C, Yang X, Yan J, Xu W. Lei M, et al. Diabetes Obes Metab. 2025 Sep;27(9):4699-4708. doi: 10.1111/dom.16505. Epub 2025 Jun 17. Diabetes Obes Metab. 2025. PMID: 40528553 Clinical Trial.
AIM: This study aims to evaluate the efficacy and safety of a tubeless open-source hybrid automated insulin delivery (OS-AID) in managing adults with type 1 diabetes mellitus (T1DM) in China, where commercial AID systems are not accessible. ...AAPS was notabl …
AIM: This study aims to evaluate the efficacy and safety of a tubeless open-source hybrid automated insulin delivery (O …
Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies.
Christiansen M, Bartee A, Lalonde A, Jones RE, Katz M, Wolpert H, Brazg R. Christiansen M, et al. Diabetes Technol Ther. 2021 Mar;23(3):187-194. doi: 10.1089/dia.2020.0318. Epub 2020 Oct 5. Diabetes Technol Ther. 2021. PMID: 32940537 Free PMC article. Clinical Trial.
Background: Automated insulin delivery (AID) systems have demonstrated improvements in time-in-range (TIR, blood glucose 70-180 mg/dL) without increasing hypoglycemia. ...Participants tested a Lilly hybrid closed-loop (HCL) system comprising an investi …
Background: Automated insulin delivery (AID) systems have demonstrated improvements in time-in-range (TIR, blood glucos …
Biosynthetic Human Insulin and Insulin Analogs.
Rodbard HW, Rodbard D. Rodbard HW, et al. Am J Ther. 2020 Jan/Feb;27(1):e42-e51. doi: 10.1097/MJT.0000000000001089. Am J Ther. 2020. PMID: 31876563 Review.
RESULTS: Basal-bolus therapy and insulin pump therapy, including closed-loop automated insulin delivery, require rapid-acting insulin analogs. The longer acting insulins can provide stable, reproducible basal insulin with reduced r …
RESULTS: Basal-bolus therapy and insulin pump therapy, including closed-loop automated insulin delivery, require …
Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA. Choudhary P, et al. Diabetes Care. 2011 Sep;34(9):2023-5. doi: 10.2337/dc10-2411. Diabetes Care. 2011. PMID: 21868778 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate a sensor-augmented insulin pump with a low glucose suspend (LGS) feature that automatically suspends basal insulin delivery for up to 2 h in response to sensor-detected hypoglycemia. ...Median sensor glucose was 3.9 mmol/L after …
OBJECTIVE: To evaluate a sensor-augmented insulin pump with a low glucose suspend (LGS) feature that automatically suspends basal …
Efficacy and Safety of a Non-Carbohydrate Counting Meal Bolus Strategy in Adults with Type 1 Diabetes Using Open-Source Automated Insulin Delivery.
Cai Y, Ma L, Zhang L, Neng Q, Su H. Cai Y, et al. Diabetes Technol Ther. 2025 Oct;27(10):831-838. doi: 10.1089/dia.2024.0591. Epub 2025 May 22. Diabetes Technol Ther. 2025. PMID: 40402843 Free article. Clinical Trial.
Aims: This study addressed the challenge of postprandial glycemic variability in type 1 diabetes (T1D), even with AID (automated insulin delivery). We evaluated the effectiveness of a non-carbohydrate counting (non-CC) meal bolus strategy in adults with T1D u …
Aims: This study addressed the challenge of postprandial glycemic variability in type 1 diabetes (T1D), even with AID (automated i …
Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
Davis T, Salahi A, Welsh JB, Bailey TS. Davis T, et al. Diabetes Obes Metab. 2015 Dec;17(12):1126-32. doi: 10.1111/dom.12542. Epub 2015 Oct 5. Diabetes Obes Metab. 2015. PMID: 26179879 Review.
Although fully automated systems that achieve consistent euglycaemia in T1D remain an elusive goal, improvements in continuous glucose monitoring (CGM) sensors and control algorithms have enabled semi-automated systems that lower the risk of hypoglycaemia, es …
Although fully automated systems that achieve consistent euglycaemia in T1D remain an elusive goal, improvements in continuous glucos …
Are nocturnal hypoglycemia prevention strategies influenced by diabetes technology usage? A BETTER registry analysis.
Talbo MK, Rabasa-Lhoret R, Yale JF, Peters TM, Brazeau AS. Talbo MK, et al. Diabetes Res Clin Pract. 2022 Sep;191:110080. doi: 10.1016/j.diabres.2022.110080. Epub 2022 Sep 12. Diabetes Res Clin Pract. 2022. PMID: 36099973
AIM: To assess the association of nocturnal hypoglycemia prevention strategies (NH-PS) and diabetes technology usage (insulin pump and/or continuous glucose monitors [CGM]) in people with type 1 diabetes (PWT1D). METHODS: Logistic regression models were used …
AIM: To assess the association of nocturnal hypoglycemia prevention strategies (NH-PS) and diabetes technology usage (insul …
Closing the loop.
Dassau E, Atlas E, Phillip M. Dassau E, et al. Int J Clin Pract Suppl. 2011 Feb;(170):20-5. doi: 10.1111/j.1742-1241.2010.02575.x. Int J Clin Pract Suppl. 2011. PMID: 21323809 Review.
However, recent improvements in both glucose-sensing technology and insulin delivery together with advanced control and systems engineering made this dream of an artificial pancreas possible. ...This may mark the beginning of a new era in diabetes management with th …
However, recent improvements in both glucose-sensing technology and insulin delivery together with advanced control and system …
23 results